These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 19050963

  • 1. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
    Modlin IM, Gustafsson BI, Drozdov I, Nadler B, Pfragner R, Kidd M.
    Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
    [Abstract] [Full Text] [Related]

  • 2. Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study.
    Zatelli MC, Torta M, Leon A, Ambrosio MR, Gion M, Tomassetti P, De Braud F, Delle Fave G, Dogliotti L, degli Uberti EC, Italian CromaNet Working Group.
    Endocr Relat Cancer; 2007 Jun; 14(2):473-82. PubMed ID: 17639060
    [Abstract] [Full Text] [Related]

  • 3. Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.
    Belli SH, Oneto A, Aranda C, O'Connor JM, Domenichini E, Roca E, Méndez G, Bestani MC, Parma P, Giacomi N, Marmissolle F.
    Acta Gastroenterol Latinoam; 2009 Sep; 39(3):184-9. PubMed ID: 19845257
    [Abstract] [Full Text] [Related]

  • 4. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM, Lou B, Ye SR, Cao M, He X, Li P, Hu K, Rao L, Wu SM, Xiao HB, Gao E.
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [Abstract] [Full Text] [Related]

  • 5. KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model.
    Siddique ZL, Drozdov I, Floch J, Gustafsson BI, Stunes K, Pfragner R, Kidd M, Modlin IM.
    Neuroendocrinology; 2009 Nov; 89(4):458-70. PubMed ID: 19295186
    [Abstract] [Full Text] [Related]

  • 6. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS.
    Cancer Res; 2001 Dec 15; 61(24):8845-50. PubMed ID: 11751407
    [Abstract] [Full Text] [Related]

  • 7. Chromogranin A: is it a useful marker of neuroendocrine tumors?
    Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, Tomassetti P.
    J Clin Oncol; 2007 May 20; 25(15):1967-73. PubMed ID: 17513802
    [Abstract] [Full Text] [Related]

  • 8. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M.
    Hepatogastroenterology; 2005 May 20; 52(63):731-41. PubMed ID: 15966194
    [Abstract] [Full Text] [Related]

  • 9. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
    Goebel SU, Serrano J, Yu F, Gibril F, Venzon DJ, Jensen RT.
    Cancer; 1999 Apr 01; 85(7):1470-83. PubMed ID: 10193936
    [Abstract] [Full Text] [Related]

  • 10. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I, Kakeji Y, Baba H, Maehara Y.
    Hepatogastroenterology; 2008 Apr 01; 55(84):1131-5. PubMed ID: 18705345
    [Abstract] [Full Text] [Related]

  • 11. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR, Teixeira E, Diamond J, Correia H, Santos S, Neto L, Ribeiro M, Miranda A, Passos-Coelho JL.
    Breast Cancer Res Treat; 2009 Mar 01; 114(2):223-32. PubMed ID: 18409061
    [Abstract] [Full Text] [Related]

  • 12. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.
    Shida T, Furuya M, Nikaido T, Kishimoto T, Koda K, Oda K, Nakatani Y, Miyazaki M, Ishikura H.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):450-8. PubMed ID: 15701827
    [Abstract] [Full Text] [Related]

  • 13. [The diagnostic value of plasma chromogranin A in neuroendocrine tumors].
    Yang XO, Li JN, Qian JM, Yang H, Chen Q, Lu L.
    Zhonghua Nei Ke Za Zhi; 2011 Feb 15; 50(2):124-7. PubMed ID: 21418832
    [Abstract] [Full Text] [Related]

  • 14. Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells.
    Müller C, Petermann D, Pfeffel F, Oesterreicher C, Függer R.
    Hepatology; 1997 Apr 15; 25(4):896-9. PubMed ID: 9096594
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors.
    Kidd M, Schally AV, Pfragner R, Malfertheiner MV, Modlin IM.
    Cancer; 2008 Mar 15; 112(6):1404-14. PubMed ID: 18224665
    [Abstract] [Full Text] [Related]

  • 16. Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors.
    Gregersen T, Grønbæk H, Worsøe J, Schlageter V, Laurberg S, Krogh K.
    Scand J Gastroenterol; 2011 Jul 15; 46(7-8):895-902. PubMed ID: 21623673
    [Abstract] [Full Text] [Related]

  • 17. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC, Garcao F, Coutinho EC, De Oliveira CF, Regateiro FJ.
    Neoplasma; 2006 Jul 15; 53(6):538-43. PubMed ID: 17167725
    [Abstract] [Full Text] [Related]

  • 18. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection.
    Modlin IM, Drozdov I, Alaimo D, Callahan S, Teixiera N, Bodei L, Kidd M.
    Endocr Relat Cancer; 2014 Aug 15; 21(4):615-28. PubMed ID: 25015994
    [Abstract] [Full Text] [Related]

  • 19. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease.
    Terrin L, Rampazzo E, Pucciarelli S, Agostini M, Bertorelle R, Esposito G, DelBianco P, Nitti D, De Rossi A.
    Clin Cancer Res; 2008 Nov 15; 14(22):7444-51. PubMed ID: 19010861
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients.
    Valladares-Ayerbes M, Díaz-Prado S, Reboredo M, Medina V, Lorenzo-Patiño MJ, Iglesias-Díaz P, Haz M, Pértega S, Santamarina I, Blanco M, Quindós-Varela M, Figueroa A, Antón-Aparicio LM.
    Cancer Epidemiol Biomarkers Prev; 2010 Jun 15; 19(6):1432-40. PubMed ID: 20501752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.